Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

MICA and recovery from hepatitis C virus and hepatitis B virus infections.

Karacki PS, Gao X, Thio CL, Thomas DL, Goedert JJ, Vlahov D, Kaslow RA, Strathdee S, Hilgartner MW, O'Brien SJ, Carrington M.

Genes Immun. 2004 Jun;5(4):261-6.

PMID:
15029237
2.

Long-term FEIBA prophylaxis does not prevent progression of existing joint disease.

Hilgartner MW, Makipernaa A, Dimichele DM.

Haemophilia. 2003 May;9(3):261-8.

PMID:
12694515
3.

End-stage liver disease in persons with hemophilia and transfusion-associated infections.

Goedert JJ, Eyster ME, Lederman MM, Mandalaki T, De Moerloose P, White GC 2nd, Angiolillo AL, Luban NL, Sherman KE, Manco-Johnson M, Preiss L, Leissinger C, Kessler CM, Cohen AR, DiMichele D, Hilgartner MW, Aledort LM, Kroner BL, Rosenberg PS, Hatzakis A.

Blood. 2002 Sep 1;100(5):1584-9.

PMID:
12176875
4.

HLA-Cw*04 and hepatitis C virus persistence.

Thio CL, Gao X, Goedert JJ, Vlahov D, Nelson KE, Hilgartner MW, O'Brien SJ, Karacki P, Astemborski J, Carrington M, Thomas DL.

J Virol. 2002 May;76(10):4792-7.

5.

Current treatment of hemophilic arthropathy.

Hilgartner MW.

Curr Opin Pediatr. 2002 Feb;14(1):46-9. Review.

PMID:
11880733
6.
7.

Racial differences in HLA class II associations with hepatitis C virus outcomes.

Thio CL, Thomas DL, Goedert JJ, Vlahov D, Nelson KE, Hilgartner MW, O'Brien SJ, Karacki P, Marti D, Astemborski J, Carrington M.

J Infect Dis. 2001 Jul 1;184(1):16-21. Epub 2001 May 30.

PMID:
11398104
8.

Relation between HIV-1 and hepatitis C viral load in patients with hemophilia.

Daar ES, Lynn H, Donfield S, Gomperts E, Hilgartner MW, Hoots WK, Chernoff D, Arkin S, Wong WY, Winkler CA; Hemophilia Growth and Development Study.

J Acquir Immune Defic Syndr. 2001 Apr 15;26(5):466-72.

PMID:
11391167
9.

The effect of plasma human immunodeficiency virus RNA and CD4(+) T lymphocytes on growth measurements of hemophilic boys and adolescents.

Hilgartner MW, Donfield SM, Lynn HS, Hoots WK, Gomperts ED, Daar ES, Chernoff D, Pearson SK; Hemophilia Growth and Development Study.

Pediatrics. 2001 Apr;107(4):E56.

PMID:
11335777
10.

Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs.

Daar ES, Lynn H, Donfield S, Gomperts E, O'Brien SJ, Hilgartner MW, Hoots WK, Chernoff D, Arkin S, Wong WY, Winkler CA; Hemophilia Growth and Development Study.

J Infect Dis. 2001 Feb 15;183(4):589-95. Epub 2001 Jan 12.

PMID:
11170984
11.

Effects of plasma HIV RNA, CD4+ T lymphocytes, and the chemokine receptors CCR5 and CCR2b on HIV disease progression in hemophiliacs. Hemophilia Growth and Development Study.

Daar ES, Lynn H, Donfield S, Gomperts E, Hilgartner MW, Hoots K, Chernoff D, Winkler C, O'Brien SJ.

J Acquir Immune Defic Syndr. 1999 Aug 1;21(4):317-25.

PMID:
10428111
12.

High prevalence of antibodies against HERV-K10 in patients with testicular cancer but not with AIDS.

Goedert JJ, Sauter ME, Jacobson LP, Vessella RL, Hilgartner MW, Leitman SF, Fraser MC, Mueller-Lantzsch NG.

Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 1):293-6.

13.

Genetic acceleration of AIDS progression by a promoter variant of CCR5.

Martin MP, Dean M, Smith MW, Winkler C, Gerrard B, Michael NL, Lee B, Doms RW, Margolick J, Buchbinder S, Goedert JJ, O'Brien TR, Hilgartner MW, Vlahov D, O'Brien SJ, Carrington M.

Science. 1998 Dec 4;282(5395):1907-11.

14.

Progression to AIDS.

Donfield SM, Lynn HS, Hilgartner MW.

Science. 1998 Jun 19;280(5371):1819-20. No abstract available.

PMID:
9669928
15.

Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study.

Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, Goedert JJ, O'Brien TR, Jacobson LP, Kaslow R, Buchbinder S, Vittinghoff E, Vlahov D, Hoots K, Hilgartner MW, O'Brien SJ.

Science. 1997 Aug 15;277(5328):959-65.

16.

`An account of an hemorrhagic disposition existing in certain families'.

Hilgartner MW.

Haemophilia. 1997 Apr;3(2):154-6. doi: 10.1046/j.1365-2516.1997.00050.x. No abstract available.

PMID:
27214728
17.

AIDS-associated non-Hodgkin's lymphomas as primary and secondary AIDS diagnoses in hemophiliacs. Hemophilia Malignancy Study Group.

Ragni MV, Belle SH, Jaffe R, Locker J, Duerstein SL, Bass DC, Addiego JE, Aledort LM, Barron LE, Brettler DB, Buchanan GR, Gill JC, Ewenstein BM, Green D, Hilgartner MW, Hoots WK, Kisker CT, Lovrien EW, Rutherford CJ, Sanders NL, Smith KJ, Stabler SP, Swindells S, White GC 3rd, Kingsley LA.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Sep;13(1):78-86.

PMID:
8797689
18.

Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study.

O'Brien TR, Blattner WA, Waters D, Eyster E, Hilgartner MW, Cohen AR, Luban N, Hatzakis A, Aledort LM, Rosenberg PS, Miley WJ, Kroner BL, Goedert JJ.

JAMA. 1996 Jul 10;276(2):105-10.

PMID:
8656501
19.

Heteroduplex analysis in hemophilia B: detection of two novel factor IX gene mutations.

Driscoll MC, Chu A, Hilgartner MW.

Am J Hematol. 1996 Apr;51(4):324-7.

20.

Human immunodeficiency virus (HIV) type 1 infection status and in vitro susceptibility to HIV infection among high-risk HIV-1-seronegative hemophiliacs.

Lederman MM, Jackson JB, Kroner BL, White GC 3rd, Eyster ME, Aledort LM, Hilgartner MW, Kessler CM, Cohen AR, Kiger KP, et al.

J Infect Dis. 1995 Jul;172(1):228-31.

PMID:
7797917
21.

Idiopathic CD4+ T-lymphocytopenia in HIV seronegative men with hemophilia and sex partners of HIV seropositive men. Multicenter Hemophilia Cohort Study.

O'Brien TR, Diamondstone L, Fried MW, Aledort LM, Eichinger S, Eyster ME, Hilgartner MW, White G, Di Bisceglie AM, Goedert JJ.

Am J Hematol. 1995 Jul;49(3):201-6.

PMID:
7604813
22.

Blood transfusions and immunophenotypic alterations of lymphocyte subsets in sickle cell anemia. The Transfusion Safety Study Group.

Wong WY, Powars DR, Operskalski EA, Hassett J, Parker JW, Sarnaik S, Pegelow CH, Hilgartner MW, Johnson CS, Zhou Y, et al.

Blood. 1995 Apr 15;85(8):2091-7.

PMID:
7718880
23.

Low risk of viral infection after administration of vapor-heated factor VII concentrate or factor IX complex in first-time recipients of blood components. International Factor Safety Study Group.

Shapiro A, Abe T, Aledort LM, Anderle K, Hilgartner MW, Kunschak M, Preston FE, Rivard GE, Schimpf K.

Transfusion. 1995 Mar;35(3):204-8.

PMID:
7878711
24.

Delayed somatic growth and pubertal development in human immunodeficiency virus-infected hemophiliac boys: Hemophilia Growth and Development Study.

Gertner JM, Kaufman FR, Donfield SM, Sleeper LA, Shapiro AD, Howard C, Gomperts ED, Hilgartner MW.

J Pediatr. 1994 Jun;124(6):896-902.

PMID:
8201473
25.

Initial presentations of pediatric hemophiliacs.

Conway JH, Hilgartner MW.

Arch Pediatr Adolesc Med. 1994 Jun;148(6):589-94.

PMID:
8193682
26.

Risk of HIV infection and AIDS in women and girls with coagulation disorders.

Goedert JJ, Garvey L, Hilgartner MW, Blatt PM, Aledort LM, Cohen AR, Kessler CM, White GC, Mandalaki T, Cook RA, et al.

AIDS. 1994 Apr;8(4):564-5. No abstract available.

PMID:
8011269
27.

The prophylactic use of porcine factor VIII.

Hilgartner MW.

Semin Hematol. 1994 Apr;31(2 Suppl 4):39-40. No abstract available.

PMID:
7939773
28.

Hepatitis A virus transmission by blood products in the United States. Transfusion Safety Study Group.

Mosley JW, Nowicki MJ, Kasper CK, Donegan E, Aledort LM, Hilgartner MW, Operskalski EA.

Vox Sang. 1994;67 Suppl 1:24-8.

PMID:
8091731
29.

Results from a phase I clinical trial of HBED.

Grady RW, Salbe AD, Hilgartner MW, Giardina PJ.

Adv Exp Med Biol. 1994;356:351-9.

PMID:
7887241
30.

Cytomegalovirus infection and risk of AIDS in human immunodeficiency virus-infected hemophilia patients. National Cancer Institute Multicenter Hemophilia Cohort Study Group.

Rabkin CS, Hatzakis A, Griffiths PD, Pillay D, Ragni MV, Hilgartner MW, Goedert JJ.

J Infect Dis. 1993 Nov;168(5):1260-3.

PMID:
7710460
31.

Changes in CD4 count relative to product usage: findings from the transfusion safety study.

Hilgartner MW.

Semin Hematol. 1993 Oct;30(4 Suppl 5):7-9. Review. No abstract available.

PMID:
7903481
32.

Vitamin K and the newborn.

Hilgartner MW.

N Engl J Med. 1993 Sep 23;329(13):957-8. No abstract available.

PMID:
8361511
33.

Purity of factor VIII concentrates and serial CD4 counts. The Transfusion Safety Study Group.

Hilgartner MW, Buckley JD, Operskalski EA, Pike MC, Mosley JW.

Lancet. 1993 May 29;341(8857):1373-4.

PMID:
8098792
34.

Hemophilia growth and development study. Design, methods, and entry data.

Hilgartner MW, Donfield SM, Willoughby A, Contant CF Jr, Evatt BL, Gomperts ED, Hoots WK, Jason J, Loveland KA, McKinlay SM, et al.

Am J Pediatr Hematol Oncol. 1993 May;15(2):208-18.

PMID:
8498644
35.

Behavioral contracting to improve adherence in patients with thalassemia.

Koch DA, Giardina PJ, Ryan M, MacQueen M, Hilgartner MW.

J Pediatr Nurs. 1993 Apr;8(2):106-11.

PMID:
8509968
36.

Loss of high-responder inhibitors in patients with severe hemophilia A and human immunodeficiency virus type 1 infection: a report from the Multi-Center Hemophilia Cohort Study.

Bray GL, Kroner BL, Arkin S, Aledort LW, Hilgartner MW, Eyster ME, Ragni MV, Goedert JJ.

Am J Hematol. 1993 Apr;42(4):375-9.

PMID:
8493988
37.

Passive antibody to hepatitis A virus in US haemophiliacs.

Nowicki MJ, Mosley JW, Koerper MA, Aledort LM, Lusher JM, Hilgartner MW.

Lancet. 1993 Feb 27;341(8844):562. No abstract available.

PMID:
8094802
38.

Human immunodeficiency virus-related conditions in children and adults with hemophilia: rates, relationship to CD4 counts, and predictive value.

Eyster ME, Rabkin CS, Hilgartner MW, Aledort LM, Ragni MV, Sprandio J, White GC, Eichinger S, de Moerloose P, Andes WA, et al.

Blood. 1993 Feb 1;81(3):828-34.

PMID:
8427974
39.

Incidence of lymphomas and other cancers in HIV-infected and HIV-uninfected patients with hemophilia.

Rabkin CS, Hilgartner MW, Hedberg KW, Aledort LM, Hatzakis A, Eichinger S, Eyster ME, White GC 2nd, Kessler CM, Lederman MM, et al.

JAMA. 1992 Feb 26;267(8):1090-4.

PMID:
1735926
40.

Update on thalassemia.

Giardina PJ, Hilgartner MW.

Pediatr Rev. 1992 Feb;13(2):55-62. Review.

PMID:
1546001
41.

Low risk of viral infection after administration of vapor-heated factor VIII concentrate. International Investigator Group.

Mannucci PM, Schimpf K, Abe T, Aledort LM, Anderle K, Brettler DB, Hilgartner MW, Kernoff PB, Kunschak M, McMillan CW, et al.

Transfusion. 1992 Feb;32(2):134-8.

PMID:
1311876
42.

Variability in serial CD4 counts and relation to progression of HIV-I infection to AIDS in haemophilic patients. Transfusion Safety Study Group.

Aledort LM, Hilgartner MW, Pike MC, Gjerset GF, Koerper MA, Lian EY, Lusher JM, Mosley JW.

BMJ. 1992 Jan 25;304(6821):212-6.

43.

Risk of human immunodeficiency virus type 1 infection among sexual and nonsexual household contacts of persons with congenital clotting disorders.

Lusher JM, Operskalski EA, Aledort LM, Dietrich SL, Gjerset GF, Hilgartner MW, Koerper MA, Pegelow CH, Lee H, Mosley JW.

Pediatrics. 1991 Aug;88(2):242-9.

PMID:
1861921
44.

Prolonged survival in patients with beta-thalassemia major treated with deferoxamine.

Ehlers KH, Giardina PJ, Lesser ML, Engle MA, Hilgartner MW.

J Pediatr. 1991 Apr;118(4 Pt 1):540-5.

PMID:
2007928
45.

The need for recombinant factor VIII: historical background and rationale.

Hilgartner MW.

Semin Hematol. 1991 Apr;28(2 Suppl 1):6-9. No abstract available.

PMID:
1908132
46.

Humoral immune responses to gag and env proteins from human immunodeficiency virus type 1 in hemophiliac patients.

Kinney JS, Conway JH, Hilgartner MW, Clayman B, Mayur K, Yolken RH, Viscidi RP.

Am J Hematol. 1991 Jan;36(1):35-41.

PMID:
1984680
47.

Iron and lymphocytes: reciprocal regulatory interactions.

de Sousa M, Reimão R, Porto G, Grady RW, Hilgartner MW, Giardina P.

Curr Stud Hematol Blood Transfus. 1991;(58):171-7. Review. No abstract available.

PMID:
1954765
48.

Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. recombinant Factor VIII Study Group.

Schwartz RS, Abildgaard CF, Aledort LM, Arkin S, Bloom AL, Brackmann HH, Brettler DB, Fukui H, Hilgartner MW, Inwood MJ, et al.

N Engl J Med. 1990 Dec 27;323(26):1800-5.

49.

Hemophiliac patients in surgery. Implications for perioperative nurses.

Kleinert D, Cahill-Bordas M, Hilgartner MW.

AORN J. 1990 Oct;52(4):743-52.

PMID:
2241126
50.

A KpnI DNA polymorphism in the human von Willebrand factor (VWF) gene.

Driscoll CM, Chiu C, Hilgartner MW.

Nucleic Acids Res. 1990 Aug 25;18(16):4968. No abstract available.

Supplemental Content

Loading ...
Support Center